Digistain logo (teal)
  • Platform
    • Overview
    • How it works
    • Research and pipeline
    • Publications
  • Products
    • Digistain Breast
  • Partners
  • Investors
  • About
    • About Digistain
    • Team
  • News
  • Contact
✕
  • Platform
    • Overview
    • How it works
    • Research and pipeline
    • Publications
  • Products
    • Digistain Breast
  • Partners
  • Investors
  • About
    • About Digistain
    • Team
  • News
  • Contact
Contact us

The MedTech Conference

  • Home
  • News
  • Conferences
  • The MedTech Conference
iop logo 1

Digistain wins the Institute of Physics Innovation award

October 24, 2022
BBC Radio logo.svg

DigiStain’s CEO Dr Hemmel Amrania on BBC Radio

November 2, 2022
iop logo 1

Digistain wins the Institute of Physics Innovation award

October 24, 2022
BBC Radio logo.svg

DigiStain’s CEO Dr Hemmel Amrania on BBC Radio

November 2, 2022
October 26, 2022
Categories
  • Conferences
Tags
WhatsApp Image 2022 10 30 at 07.11.16

Excited to be in Boston, MA for the Med Tech Conference. Here Digistain is keeping up to date on the latest health-tech updates and regulatory changes

Share
admin

admin

Related posts

1746820935131
May 9, 2025

ASBRS2025


Read more
footer logo 2024
December 16, 2024

Digistain Presents Key Research Findings at the San Antonio Breast Cancer Symposium 2024


Read more
spinoff digistain
October 11, 2023

Digistain at Spinoff Bulgaria 2023


Read more

Comments are closed.

Digistain

Digistain is a cancer biomarker company. Its breast cancer recurrence-risk test measures the tumour’s biochemistry directly, with results before the next appointment.

LRQA certified ISO 13485

Platform

  • Overview
  • How it works
  • Research and pipeline
  • Publications

Digistain Breast

  • Overview
  • For clinicians
  • For laboratories
  • For patients

Company

  • Partners
  • Investors
  • About
  • Team
  • News
  • Contact
© 2026 Digistain Ltd · ISO 13485:2016 certified (LRQA) for the design and development of IVD software used in cancer management · Privacy policy · Terms and conditions · Cookie policy